Lower-dose warfarin delays renal progression and prolongs patient survival in patients with stage 3 â 5 chronic kidney disease and nonvalvular atrial fibrillation: a 12-year follow-up study
Lower-dose warfarin delays renal progression and prolongs patient survival in patients with stage 3 â 5 chronic kidney disease and nonvalvular atrial fibrillation: a 12-year follow-up study
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now